Being in nature should be calming, amid chirping birds, buzzing bees, burbling brooks. But pollen, in a sneak attack, makes allergy sufferers erupt into a sneezing, watery-eyed mess. It’s not easy to predict when seasonal allergies will strike — but it’s a question researchers at Palo Alto-based startup doc.ai are tackling with their first data trial.
Doc.ai built a mobile app that connects healthcare companies and medical researchers with smartphone users. App users elect to become research participants in data trials, sharing their anonymized information in exchange for health insights and compensation through blockchain tokens. The first of these trials focuses on allergies, while upcoming trials span a range of medical research areas and diseases.
